NPI: 1033749940 · FLINT, MI 48504 · Clinical Medical Laboratory · NPI assigned 01/20/2020
Authorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
| Authorized Official | BOWLES, CHARLES (VICE PRESIDENT) |
| Parent Organization | QUEST DIAGNOSTICS INCORPORATED |
| NPI Enumeration Date | 01/20/2020 |
Other providers sharing the same authorized official: BOWLES, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 100,883 | $1.65M |
| 2021 | 178,277 | $2.80M |
| 2022 | 123,963 | $1.86M |
| 2024 | 96,832 | $1.29M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16,060 | 15,241 | $1.56M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 16,210 | 12,658 | $505K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 9,272 | 7,536 | $449K |
| 81513 | 3,232 | 3,187 | $379K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 9,711 | 9,559 | $335K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 18,683 | 18,013 | $330K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 4,711 | 3,349 | $321K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 18,579 | 17,895 | $310K |
| 80050 | General health panel | 14,625 | 14,555 | $226K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 15,982 | 15,899 | $219K |
| 80061 | Lipid panel | 31,448 | 31,305 | $215K |
| 87799 | 4,805 | 4,660 | $190K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 10,600 | 10,567 | $148K |
| 80053 | Comprehensive metabolic panel | 23,749 | 23,353 | $144K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 5,785 | 5,778 | $116K |
| 84443 | Thyroid stimulating hormone (TSH) | 13,968 | 13,896 | $116K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 24,306 | 23,656 | $108K |
| 86769 | 2,407 | 2,400 | $106K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 6,383 | 6,382 | $99K |
| 86480 | 2,331 | 2,324 | $84K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 21,168 | 21,124 | $83K |
| 87512 | 4,699 | 4,653 | $61K | |
| 86003 | 1,013 | 978 | $61K | |
| 82607 | 6,319 | 6,297 | $55K | |
| 86803 | 6,692 | 6,647 | $50K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1,029 | 1,007 | $49K |
| 80081 | 1,145 | 1,145 | $48K | |
| 83013 | 1,176 | 1,154 | $46K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 185 | 184 | $45K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 10,154 | 9,897 | $41K |
| 82746 | 4,725 | 4,717 | $40K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 9,865 | 9,650 | $39K |
| 84439 | 7,259 | 7,220 | $34K | |
| 82728 | 5,191 | 5,158 | $33K | |
| 86235 | 661 | 656 | $33K | |
| 87088 | 7,805 | 7,649 | $32K | |
| 84153 | 3,445 | 3,427 | $32K | |
| 84403 | 1,765 | 1,747 | $26K | |
| 80074 | 2,242 | 2,224 | $26K | |
| 86696 | 1,817 | 1,801 | $25K | |
| 87522 | Neg quan hep c or qual rna | 911 | 901 | $22K |
| 85027 | 5,934 | 5,854 | $22K | |
| 87536 | 458 | 457 | $21K | |
| 82652 | 1,429 | 1,421 | $20K | |
| 87340 | 3,740 | 3,730 | $20K | |
| 83550 | 4,816 | 4,762 | $19K | |
| 88142 | 1,613 | 1,612 | $19K | |
| 86592 | 7,636 | 7,575 | $19K | |
| 81001 | 9,971 | 9,833 | $18K | |
| 83001 | 1,601 | 1,584 | $17K | |
| 86038 | 2,313 | 2,298 | $16K | |
| 86695 | 1,736 | 1,727 | $16K | |
| 82043 | 4,879 | 4,862 | $16K | |
| 83540 | 5,188 | 5,116 | $16K | |
| 82670 | 984 | 972 | $16K | |
| 82570 | 5,493 | 5,414 | $15K | |
| 83655 | 2,108 | 2,104 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 3,172 | 3,106 | $15K |
| 87800 | 1,434 | 1,417 | $15K | |
| 83002 | 1,306 | 1,299 | $14K | |
| 87186 | 2,814 | 2,693 | $14K | |
| 84146 | 1,253 | 1,244 | $14K | |
| 87070 | 2,726 | 2,699 | $14K | |
| 88141 | 950 | 949 | $13K | |
| 87077 | 2,766 | 2,614 | $13K | |
| 83735 | 3,398 | 3,339 | $13K | |
| 84402 | 799 | 790 | $12K | |
| 84702 | 2,754 | 2,457 | $12K | |
| 84481 | 1,126 | 1,121 | $11K | |
| 83970 | 486 | 477 | $11K | |
| 84550 | 4,009 | 3,946 | $11K | |
| 86364 | 145 | 145 | $10K | |
| 87563 | 425 | 420 | $9K | |
| 82785 | 787 | 786 | $8K | |
| 86140 | 2,286 | 2,139 | $7K | |
| 86200 | 889 | 877 | $7K | |
| 86704 | 1,093 | 1,088 | $7K | |
| 86376 | 745 | 734 | $6K | |
| 86787 | 822 | 816 | $6K | |
| 86706 | 1,115 | 1,111 | $6K | |
| 82627 | 446 | 441 | $6K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 26 | 26 | $6K |
| 84436 | 2,002 | 1,995 | $6K | |
| 87081 | 1,466 | 1,459 | $6K | |
| 83520 | 1,097 | 593 | $5K | |
| 86708 | 872 | 867 | $5K | |
| 83525 | 785 | 779 | $5K | |
| 86431 | 1,541 | 1,533 | $5K | |
| 83880 | 232 | 227 | $5K | |
| 86360 | 188 | 188 | $5K | |
| 83690 | 1,191 | 1,183 | $5K | |
| 86780 | 628 | 624 | $5K | |
| 84480 | 711 | 708 | $5K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 67 | 66 | $5K |
| 84479 | 1,479 | 1,478 | $4K | |
| 86317 | 512 | 510 | $4K | |
| 87147 | 1,379 | 1,369 | $4K | |
| 84460 | 1,413 | 1,372 | $4K | |
| 85652 | 2,638 | 2,528 | $4K | |
| 82950 | 1,506 | 1,493 | $4K | |
| 84270 | 459 | 454 | $4K | |
| 82565 | 1,402 | 1,353 | $4K | |
| 80051 | 963 | 942 | $4K | |
| 82105 | 505 | 502 | $4K | |
| 84450 | 1,311 | 1,276 | $4K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 43 | 43 | $4K |
| 86762 | 435 | 434 | $4K | |
| 83020 | 497 | 494 | $4K | |
| 84144 | 300 | 287 | $4K | |
| 87902 | 24 | 24 | $4K | |
| 84100 | 1,307 | 1,279 | $4K | |
| 82550 | 916 | 848 | $3K | |
| 83516 | 673 | 362 | $3K | |
| 82150 | 875 | 870 | $3K | |
| 86225 | 400 | 396 | $3K | |
| 81511 | 50 | 50 | $3K | |
| 83014 | 675 | 671 | $3K | |
| 80076 | 640 | 623 | $3K | |
| 82248 | 1,022 | 1,000 | $3K | |
| 86039 | 445 | 443 | $3K | |
| 85610 | 1,707 | 1,514 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 183 | 83 | $3K |
| 84154 | 271 | 270 | $3K | |
| 84520 | 1,245 | 1,205 | $3K | |
| 86800 | 278 | 277 | $3K | |
| 82947 | 1,134 | 1,132 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 48 | 48 | $2K |
| 82310 | 824 | 803 | $2K | |
| 82784 | 307 | 305 | $2K | |
| 83021 | 230 | 230 | $2K | |
| 84156 | 1,050 | 1,010 | $2K | |
| 87625 | 96 | 96 | $2K | |
| 86160 | 147 | 144 | $2K | |
| 82977 | 482 | 479 | $2K | |
| 84703 | 389 | 379 | $2K | |
| 82465 | 682 | 674 | $2K | |
| 84681 | 118 | 118 | $1K | |
| 85730 | 837 | 828 | $1K | |
| 83721 | 243 | 243 | $1K | |
| 83615 | 363 | 359 | $1K | |
| 80164 | 155 | 152 | $1K | |
| 82951 | 165 | 164 | $1K | |
| 86850 | 496 | 495 | $1K | |
| 82040 | 350 | 340 | $872.24 | |
| 86008 | 12 | 12 | $845.12 | |
| 86900 | 500 | 488 | $828.78 | |
| 85018 | 627 | 625 | $807.09 | |
| 86901 | 483 | 476 | $799.21 | |
| 85660 | 236 | 236 | $737.99 | |
| 84075 | 265 | 255 | $714.27 | |
| 85014 | 468 | 468 | $592.50 | |
| 83498 | 38 | 38 | $586.08 | |
| 87205 | 239 | 235 | $585.85 | |
| 82247 | 184 | 173 | $452.74 | |
| 86812 | 27 | 27 | $419.70 | |
| 81015 | 239 | 238 | $399.12 | |
| 81003 | 319 | 318 | $385.80 | |
| 84155 | 208 | 201 | $380.06 | |
| 86255 | 63 | 36 | $365.04 | |
| 82533 | 39 | 38 | $361.00 | |
| 86147 | 34 | 12 | $329.70 | |
| 86705 | 129 | 129 | $257.60 | |
| 87075 | 40 | 40 | $218.49 | |
| 86709 | 128 | 128 | $216.21 | |
| 87481 | 13 | 13 | $195.03 | |
| 82952 | 80 | 80 | $179.64 | |
| 84478 | 52 | 50 | $145.55 | |
| 87102 | 29 | 29 | $142.10 | |
| 82274 | 15 | 15 | $139.20 | |
| 83090 | 13 | 13 | $135.46 | |
| 83718 | 27 | 27 | $123.10 | |
| 86593 | 46 | 46 | $117.28 | |
| 80069 | 26 | 25 | $112.98 | |
| 86141 | 14 | 14 | $98.97 | |
| 85045 | 40 | 39 | $83.23 | |
| 80178 | 14 | 14 | $50.18 | |
| 85007 | 24 | 24 | $46.00 | |
| 84132 | 46 | 46 | $25.56 | |
| 84295 | 43 | 43 | $23.84 | |
| 82435 | 41 | 41 | $17.04 | |
| 82374 | 40 | 40 | $15.10 | |
| 85041 | 40 | 40 | $5.58 | |
| 85049 | 38 | 38 | $2.76 | |
| 36415 | Collection of venous blood by venipuncture | 620 | 597 | $0.10 |
| 82172 | 37 | 37 | $0.00 | |
| 85060 | 89 | 88 | $0.00 | |
| 85048 | 37 | 37 | $0.00 | |
| 85004 | 20 | 20 | $0.00 |